⚕ GalenOps CRO console
← 701 (USA)

701-1239

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2014-01-11
Adverse events
10
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-20 (study day 10.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2014-01-20 (study day 10.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 2.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 2.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03; relationship: REMOTE

mild assessed 2026-08-18

Mild HORDEOLUM — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-04; relationship: NONE

mild assessed 2026-08-18

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-13 (study day 3.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild SKIN ODOUR ABNORMAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 2.0); relationship: REMOTE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-20 (study day 41.0); relationship: NONE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2014-02-20 (study day 41.0); relationship: NONE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.